Improved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene Transfer
- 1 July 2009
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 20 (7) , 767-776
Abstract
Gene therapy for hemophilia B has been shown to result in long-term expression and immune tolerance to factor IX (F.IX) after in vivo transduction of hepatocytes with adeno-associated viral (AAV-2) vectors in experimental animals. An optimized protocol was effective in several strains of mice with a factor 9 gene deletion (F9 −/− ). However, immune responses against F.IX were repeatedly observed in C3H/HeJ F9 −/− mice. We sought to establish a gene transfer protocol that results in sustained expression without a requirement for additional manipulation of the immune system. Compared with AAV-2, AAV-8 was more efficient in transgene expression and induction of tolerance to F.IX in three different strains of wild-type mice. At equal vector doses, AAV-8 induced transgene product-specific regulatory CD4 + CD25 + FoxP3 + T cells at significantly higher frequency. Moreover, sustained correction of hemophilia B in C3H/HeJ F9 −/− mice without antibody formation was documented in all animals treated with ≥4 × 10 11 vector genomes (VG)/kg and in 80% of mice treated with 8 × 10 10 VG/kg. Therefore, it is possible to develop a gene transfer protocol that reliably induces tolerance to F.IX largely independent of genetic factors. A comparison with other studies suggests that additional parameters besides plateau levels of F.IX expression contributed to the improved success rate of tolerance induction.Keywords
This publication has 40 references indexed in Scilit:
- Transduction Efficiency and Immune Response Associated With the Administration of AAV8 Vector Into Dog Skeletal MuscleMolecular Therapy, 2009
- Coaxing the liver into preventing autoimmune disease in the brainJournal of Clinical Investigation, 2008
- Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific TregsJournal of Clinical Investigation, 2008
- Enhanced Response to Enzyme Replacement Therapy in Pompe Disease after the Induction of Immune ToleranceThe American Journal of Human Genetics, 2007
- Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferBlood, 2007
- Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouseProceedings of the National Academy of Sciences, 2007
- Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and miceThrombosis Research, 2007
- Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primatesBlood, 2006
- Immune deviation by mucosal antigen administration suppresses gene-transfer–induced inhibitor formation to factor IXBlood, 2006
- Major role of local immune responses in antibody formation to factor IX in AAV gene transferGene Therapy, 2005